C5i, the enterprise AI and data analytics firm backed by 360 ONE Asset Management, has filed confidential IPO papers with SEBI targeting a raise of \u20b91,000-1,200 crore, nearly double its abandoned 2022 attempt at \u20b9600 crore. Founded in 2000, the company posted 26% revenue growth to \u20b9545.3 crore in FY25, though net profit fell 15% to \u20b948.3 crore. Two acquisitions, UK-based Datavid for roughly $50 million and Analytic Edge for $30-40 million, sit behind that revenue surge heading into the listing<\/a>.<\/p>\n C5i derives 74% of its revenue from the US market, which means its IPO valuation argument is essentially a claim about the willingness of large American enterprises to keep paying for third-party AI and analytics services rather than building in-house or consolidating onto hyperscaler-native tools. If you’re a CEO currently running a vendor consolidation exercise, C5i’s filing is a useful proxy for where independent analytics vendors think the market is going, and whether their growth story is one you’re funding.<\/p>\n The profit compression deserves more weight than it’s getting in the headline numbers. Revenue up 26%, profit down 15%, with roughly $80-90 million deployed on acquisitions in the last two years, means C5i is buying growth ahead of a public listing, a pattern every CEO has seen before. The confidential filing route, a mechanism SEBI allows so companies can adjust terms before full public disclosure, gives C5i room to fine-tune the narrative. That’s not inherently suspicious, but it does mean the final prospectus will tell a tidier story than the underlying trend suggests.<\/p>\n The company that goes public here isn’t Course5 Intelligence the organic analytics shop, it’s a rolled-up entity that has absorbed Datavid’s data engineering capabilities and Analytic Edge’s marketing measurement tools. Whether that composite holds together as a coherent AI services business, or whether the public markets will demand a cleaner product story, is the question the S-1 equivalent will have to answer. I’d revise this read if the final DRHP shows that acquired revenue is already margin-accretive rather than dilutive.<\/p>\nWhat this means for your business<\/h2>\n